Dimetiltriptamina (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dimetiltriptamina" in Catalan language version.

Last modified: 23:13:06, 16 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank Catalan rank

1614nih.gov

5^th place

7^th place

1513doi.org

2^nd place

4^th place

33web.archive.org

1^st place

33archive.org

6^th place

15^th place

33erowid.org

3,273^rd place

4,924^th place

21kirasalak.com

low place

21oxfordjournals.org

1,550^th place

455^th place

11crfdl.org

low place

11nrc.ca

low place

11jeremybigwood.net

low place

11acs.org

865^th place

519^th place

11springerlink.com

3,167^th place

558^th place

11rickstrassman.com

low place

11npr.org

114^th place

238^th place

11csp.org

low place

acs.org (Global: 865^th place; Catalan: 519^th place)

pubs.acs.org

Hochstein, F. A.; Paradies, Anita M. «Alkaloids of Banisteria caapi and Prestonia amazonicum» (en anglès). American Chemical Society, 01-05-2002. DOI: 10.1021/ja01578a041. [Consulta: 18 desembre 2024].

archive.org (Global: 6^th place; Catalan: 15^th place)

Axelrod J. «Enzymatic formation of psychotomimetic metabolites from normally occurring compounds». Science, 134, agost 1961, p. 343. DOI: 10.1126/science.134.3475.343. PMID: 13685339.
Haroz, R; Greenberg, M «Emerging Drugs of Abuse». Medical Clinics of North America, 89, 6, 2005, p. 1259. DOI: 10.1016/j.mcna.2005.06.008. PMID: 16227062.
Strassman, Rick J. DMT: The Spirit Molecule. A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences. Rochester, Vt: Park Street, 2001. ISBN 978-0892819270. («Chapter summaries». Arxivat de l'original el 2007-01-09. [Consulta: 13 gener 2007].)

crfdl.org (Global: low place; Catalan: low place)

McKenna D.J., Towers G.H.N., Abbott F. «Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of ayahuasca» (PDF). Journal of Ethnopharmacology, 10, 2, abril 1984, p. 195–223. DOI: 10.1016/0378-8741(84)90003-5. PMID: 6587171.^{[Enllaç no actiu]}

csp.org (Global: low place; Catalan: low place)

«Church of the Holy Light of the Queen v. Mukasey». Arxivat de l'original el 2011-10-03. [Consulta: 12 desembre 2010].

doi.org (Global: 2^nd place; Catalan: 4^th place)

dx.doi.org

McKenna D.J., Towers G.H.N., Abbott F. «Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of ayahuasca» (PDF). Journal of Ethnopharmacology, 10, 2, abril 1984, p. 195–223. DOI: 10.1016/0378-8741(84)90003-5. PMID: 6587171.^{[Enllaç no actiu]}
Hochstein, F. A.; Paradies, Anita M. «Alkaloids of Banisteria caapi and Prestonia amazonicum» (en anglès). American Chemical Society, 01-05-2002. DOI: 10.1021/ja01578a041. [Consulta: 18 desembre 2024].
Axelrod J. «Enzymatic formation of psychotomimetic metabolites from normally occurring compounds». Science, 134, agost 1961, p. 343. DOI: 10.1126/science.134.3475.343. PMID: 13685339.
Rosengarten H., Friedhoff A.J. «A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances». Schizophrenia Bulletin, 2, 1, 1976, p. 90–105. DOI: 10.1093/schbul/2.1.90. PMID: 779022.
Kärkkäinen J., Forsström T., Tornaeus J., Wähälä K., Kiuru P., Honkanen A., Stenman U.-H., Turpeinen U., Hesso A. «Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues». Scandinavian Journal of Clinical and Laboratory Investigation, 65, 3, abril 2005, p. 189–199. DOI: 10.1080/00365510510013604. PMID: 16095048.
Rosengarten H., Meller E., Friedhoff A.J. «Possible source of error in studies of enzymatic formation of dimethyltryptamine». Journal of Psychiatric Research, 13, 1, 1976, p. 23–30. DOI: 10.1016/0022-3956(76)90006-6. PMID: 1067427.
Stramentinoli G., Baldessarini R.J. «Lack of enhancement of dimethyltryptamine formation in rat brain and rabbit lung in vivo by methionine or S-adenosylmethionine». Journal of Neurochemistry, 31, 4, octubre 1978, p. 1015–20. DOI: 10.1111/j.1471-4159.1978.tb00141.x. PMID: 279646.
Barker S.A., Monti J.A., Christian S.T. «N, N-dimethyltryptamine: an endogenous hallucinogen». International Review of Neurobiology, 22, 1981, p. 83–110. DOI: 10.1016/S0074-7742(08)60291-3. PMID: 6792104.
Barker S.A., Beaton J.M., Christian S.T., Monti J.A., Morris P.E. «Comparison of the brain levels of N,N-dimethyltryptamine and α, α, β, β-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect». Biochemical Pharmacology, 31, 15, agost 1982, p. 2513–6. DOI: 10.1016/0006-2952(82)90062-4. PMID: 6812592.
Best J, Nijhout HF, Reed M «Serotonin synthesis, release and reuptake in terminals: a mathematical model». Theoretical Biology & Medical Modelling, 7, 2010, p. 34. DOI: 10.1186/1742-4682-7-34. PMC: 2942809. PMID: 20723248.
Kaplan J., Mandel L.R., Stillman R., Walker R.W., VandenHeuvel W.J., Gillin J.C., Wyatt R.J. «Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects» (PDF). Psychopharmacologia, 38, 3, 1974, p. 239–45. DOI: 10.1007/BF00421376. PMID: 4607811.^{[Enllaç no actiu]}
Keiser M.J., Setola V., Irwin J.J., Laggner C., Abbas A.I., Hufeisen S.J., Jensen N.H. et al. «Predicting new molecular targets for known drugs». Nature, 462, 7270, novembre 2009, p. 175–81. DOI: 10.1038/nature08506. PMC: 2784146. PMID: 19881490.
Haroz, R; Greenberg, M «Emerging Drugs of Abuse». Medical Clinics of North America, 89, 6, 2005, p. 1259. DOI: 10.1016/j.mcna.2005.06.008. PMID: 16227062.

erowid.org (Global: 3,273^rd place; Catalan: 4,924^th place)

^{[enllaç sense format]} http://www.erowid.org/chemicals/dmt/dmt.shtml
Erowid. «5-MeO-DMT dosage». Erowid 5-MeO-DMT Vault, 14-02-1999. [Consulta: 8 desembre 2010].
Schaepe, Herbert. «International control of the preparation "ayahuasca"» (JPG). Erowid, 2001. [Consulta: 29 novembre 2010].

jeremybigwood.net (Global: low place; Catalan: low place)

Bigwood J., Ott J. «DMT: the fifteen minute trip». Head, 2, 4, novembre 1977, p. 56-61. Arxivat de l'original el 2006-01-27 [Consulta: 28 novembre 2010].

kirasalak.com (Global: low place; Catalan: low place)

Salak, Kira. «Hell and back». National Geographic Adventure.

nih.gov (Global: 5^th place; Catalan: 7^th place)

ncbi.nlm.nih.gov

McKenna D.J., Towers G.H.N., Abbott F. «Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of ayahuasca» (PDF). Journal of Ethnopharmacology, 10, 2, abril 1984, p. 195–223. DOI: 10.1016/0378-8741(84)90003-5. PMID: 6587171.^{[Enllaç no actiu]}
Axelrod J. «Enzymatic formation of psychotomimetic metabolites from normally occurring compounds». Science, 134, agost 1961, p. 343. DOI: 10.1126/science.134.3475.343. PMID: 13685339.
Rosengarten H., Friedhoff A.J. «A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances». Schizophrenia Bulletin, 2, 1, 1976, p. 90–105. DOI: 10.1093/schbul/2.1.90. PMID: 779022.
Kärkkäinen J., Forsström T., Tornaeus J., Wähälä K., Kiuru P., Honkanen A., Stenman U.-H., Turpeinen U., Hesso A. «Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues». Scandinavian Journal of Clinical and Laboratory Investigation, 65, 3, abril 2005, p. 189–199. DOI: 10.1080/00365510510013604. PMID: 16095048.
Rosengarten H., Meller E., Friedhoff A.J. «Possible source of error in studies of enzymatic formation of dimethyltryptamine». Journal of Psychiatric Research, 13, 1, 1976, p. 23–30. DOI: 10.1016/0022-3956(76)90006-6. PMID: 1067427.
Stramentinoli G., Baldessarini R.J. «Lack of enhancement of dimethyltryptamine formation in rat brain and rabbit lung in vivo by methionine or S-adenosylmethionine». Journal of Neurochemistry, 31, 4, octubre 1978, p. 1015–20. DOI: 10.1111/j.1471-4159.1978.tb00141.x. PMID: 279646.
Barker S.A., Monti J.A., Christian S.T. «N, N-dimethyltryptamine: an endogenous hallucinogen». International Review of Neurobiology, 22, 1981, p. 83–110. DOI: 10.1016/S0074-7742(08)60291-3. PMID: 6792104.
Barker S.A., Beaton J.M., Christian S.T., Monti J.A., Morris P.E. «Comparison of the brain levels of N,N-dimethyltryptamine and α, α, β, β-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect». Biochemical Pharmacology, 31, 15, agost 1982, p. 2513–6. DOI: 10.1016/0006-2952(82)90062-4. PMID: 6812592.
Sangiah S., Gomez M.V., Domino E.F. «Accumulation of N,N-dimethyltryptamine in rat brain cortical slices». Biological Psychiatry, 14, 6, desembre 1979, p. 925–36. PMID: 41604.
Best J, Nijhout HF, Reed M «Serotonin synthesis, release and reuptake in terminals: a mathematical model». Theoretical Biology & Medical Modelling, 7, 2010, p. 34. DOI: 10.1186/1742-4682-7-34. PMC: 2942809. PMID: 20723248.
Kaplan J., Mandel L.R., Stillman R., Walker R.W., VandenHeuvel W.J., Gillin J.C., Wyatt R.J. «Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects» (PDF). Psychopharmacologia, 38, 3, 1974, p. 239–45. DOI: 10.1007/BF00421376. PMID: 4607811.^{[Enllaç no actiu]}
Strassman R.J., Qualls C.R. «Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects». Archives of General Psychiatry, 51, 2, febrer 1994, p. 85–97. PMID: 8297216.
Keiser M.J., Setola V., Irwin J.J., Laggner C., Abbas A.I., Hufeisen S.J., Jensen N.H. et al. «Predicting new molecular targets for known drugs». Nature, 462, 7270, novembre 2009, p. 175–81. DOI: 10.1038/nature08506. PMC: 2784146. PMID: 19881490.
Haroz, R; Greenberg, M «Emerging Drugs of Abuse». Medical Clinics of North America, 89, 6, 2005, p. 1259. DOI: 10.1016/j.mcna.2005.06.008. PMID: 16227062.

npr.org (Global: 114^th place; Catalan: 238^th place)

^{[enllaç sense format]} http://www.npr.org/templates/story/story.php?storyId=104240746&sc=fb&cc=fp

nrc.ca (Global: low place; Catalan: low place)

rparticle.web-p.cisti.nrc.ca

Manske R.H.F. «A synthesis of the methyltryptamines and some derivatives». Canadian Journal of Research, 5, 5, 1931, p. 592–600.^{[Enllaç no actiu]}

oxfordjournals.org (Global: 1,550^th place; Catalan: 455^th place)

schizophreniabulletin.oxfordjournals.org

Rosengarten H., Friedhoff A.J. «A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances». Schizophrenia Bulletin, 2, 1, 1976, p. 90–105. DOI: 10.1093/schbul/2.1.90. PMID: 779022.

rickstrassman.com (Global: low place; Catalan: low place)

Strassman, Rick J. DMT: The Spirit Molecule. A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences. Rochester, Vt: Park Street, 2001. ISBN 978-0892819270. («Chapter summaries». Arxivat de l'original el 2007-01-09. [Consulta: 13 gener 2007].)

springerlink.com (Global: 3,167^th place; Catalan: 558^th place)

Kaplan J., Mandel L.R., Stillman R., Walker R.W., VandenHeuvel W.J., Gillin J.C., Wyatt R.J. «Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects» (PDF). Psychopharmacologia, 38, 3, 1974, p. 239–45. DOI: 10.1007/BF00421376. PMID: 4607811.^{[Enllaç no actiu]}

web.archive.org (Global: 1^st place; Catalan: 1^st place)

Bigwood J., Ott J. «DMT: the fifteen minute trip». Head, 2, 4, novembre 1977, p. 56-61. Arxivat de l'original el 2006-01-27 [Consulta: 28 novembre 2010].
Strassman, Rick J. DMT: The Spirit Molecule. A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences. Rochester, Vt: Park Street, 2001. ISBN 978-0892819270. («Chapter summaries». Arxivat de l'original el 2007-01-09. [Consulta: 13 gener 2007].)
«Church of the Holy Light of the Queen v. Mukasey». Arxivat de l'original el 2011-10-03. [Consulta: 12 desembre 2010].

Dimetiltriptamina (Catalan Wikipedia)

acs.org (Global: 865th place; Catalan: 519th place)

pubs.acs.org

archive.org (Global: 6th place; Catalan: 15th place)

crfdl.org (Global: low place; Catalan: low place)

csp.org (Global: low place; Catalan: low place)

doi.org (Global: 2nd place; Catalan: 4th place)

dx.doi.org

erowid.org (Global: 3,273rd place; Catalan: 4,924th place)

jeremybigwood.net (Global: low place; Catalan: low place)

kirasalak.com (Global: low place; Catalan: low place)

nih.gov (Global: 5th place; Catalan: 7th place)

ncbi.nlm.nih.gov

npr.org (Global: 114th place; Catalan: 238th place)

nrc.ca (Global: low place; Catalan: low place)

rparticle.web-p.cisti.nrc.ca

oxfordjournals.org (Global: 1,550th place; Catalan: 455th place)

schizophreniabulletin.oxfordjournals.org

rickstrassman.com (Global: low place; Catalan: low place)

springerlink.com (Global: 3,167th place; Catalan: 558th place)

web.archive.org (Global: 1st place; Catalan: 1st place)

acs.org (Global: 865^th place; Catalan: 519^th place)

archive.org (Global: 6^th place; Catalan: 15^th place)

doi.org (Global: 2^nd place; Catalan: 4^th place)

erowid.org (Global: 3,273^rd place; Catalan: 4,924^th place)

nih.gov (Global: 5^th place; Catalan: 7^th place)

npr.org (Global: 114^th place; Catalan: 238^th place)

oxfordjournals.org (Global: 1,550^th place; Catalan: 455^th place)

springerlink.com (Global: 3,167^th place; Catalan: 558^th place)

web.archive.org (Global: 1^st place; Catalan: 1^st place)